Covered recipient · General Payments record
ADEL CATHERINE PONDER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022–2023
$1,138.16
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $889.57 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $124.99 | 1 |
| Xeris Pharmaceuticals, Inc. | $124.99 | 1 |
| Otsuka America Pharmaceutical, Inc. | $120.99 | 1 |
| Inspire Medical Systems, Inc. | $104.86 | 1 |
| BioXcel Therapeutics, Inc. | $104.64 | 1 |
| Regeneron Healthcare Solutions, Inc. | $99.63 | 1 |
| ITI, Inc. | $88.84 | 1 |
| Neurelis, Inc. | $84.76 | 1 |
| Alnylam Pharmaceuticals Inc. | $35.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.99 | 12/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009287661 | CMS |
| Alnylam Pharmaceuticals Inc. | $35.87 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006189359 | CMS |
| BioXcel Therapeutics, Inc. | $104.64 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057524887 | CMS |
| Inspire Medical Systems, Inc. | $104.86 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1058927907 | CMS |
| ITI, Inc. | $88.84 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041085387 | CMS |
| Neurelis, Inc. | $84.76 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050940975 | CMS |
| Otsuka America Pharmaceutical, Inc. | $120.99 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015494863 | CMS |
| Regeneron Healthcare Solutions, Inc. | $99.63 | 09/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999846055 | CMS |
| Xeris Pharmaceuticals, Inc. | $124.99 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056521031 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.